Cargando…

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension

BACKGROUND: To observe different roles of direct bilirubin (Dbil) on portopulmonary hypertension (POPH) and idiopathic pulmonary arterial hypertension (IPAH). METHODS: Thirty incident patients with POPH and 180 with IPAH (matched by the WHO functional classification in a 1 : 6 ratio) between March 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuan, Qiu, Hongling, Zhao, Qinhua, He, Jing, Jiang, Rong, Wu, Wenhui, Luo, Cijun, Li, Huiting, Wang, Lan, Liu, Jinming, Gong, Sugang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159212/ https://www.ncbi.nlm.nih.gov/pubmed/35685569 http://dx.doi.org/10.1155/2022/7021178

Ejemplares similares

Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China
por: Luo, Cijun, et al.
Publicado: (2021)

Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response
por: Sun, Yuanyuan, et al.
Publicado: (2020)

Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2021)

The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension
por: Wei, Yaqin, et al.
Publicado: (2023)

The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension
por: Huai, Xu, et al.
Publicado: (2021)

Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010)

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry
por: DuBrock, Hilary M., et al.
Publicado: (2021)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension
por: Saleemi, Sarfraz, et al.
Publicado: (2014)

Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia
por: Xiong, Wei, et al.
Publicado: (2018)

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2022)

Possible use of pulmonary artery stiffness in screening for portopulmonary hypertension
por: Wessels, Jeroen N., et al.
Publicado: (2022)

Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
por: Yuan, Xuntao, et al.
Publicado: (2020)

Portopulmonary Hypertension: An Updated Review
por: Jasso-Baltazar, Erick A., et al.
Publicado: (2023)

The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease
por: Zhong, Xiujun, et al.
Publicado: (2021)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis
por: Sun, Yuanyuan, et al.
Publicado: (2022)

Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020)

Causes and Circumstances of Death in Portopulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

Portopulmonary hypertension: Success with combined medical treatment
por: Hernández, María, et al.
Publicado: (2023)

Portopulmonary hypertension caused by portal hypertension that is complicated by central diabetes insipidus
por: Zhao, Tingting, et al.
Publicado: (2020)

The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
por: Takahashi, Yukiko, et al.
Publicado: (2021)

Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023)

Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan
por: Tokushige, Katsutoshi, et al.
Publicado: (2023)

Cognitive Dysfunction in Patients with Pulmonary Hypertension
por: Yuan, Ping, et al.
Publicado: (2022)

Usefulness of Decrease in Oxygen Uptake Efficiency to Identify Gas Exchange Abnormality in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Tan, Xiaoyue, et al.
Publicado: (2014)

Left main coronary artery compression in a patient with portopulmonary hypertension
por: de Araújo, Iara Teixeira, et al.
Publicado: (2018)

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients
por: Li, Jian, et al.
Publicado: (2018)

The early outcomes of candidates with portopulmonary hypertension after liver transplantation
por: Huang, Bingsong, et al.
Publicado: (2018)

Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors
por: CHEN, HUI-SONG, et al.
Publicado: (2013)

Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review
por: Li, Niuniu, et al.
Publicado: (2023)

The Correlation of Decreased Heart Rate Recovery and Chronotropic Incompetence with Exercise Capacity in Idiopathic Pulmonary Arterial Hypertension Patients
por: Wu, Changwei, et al.
Publicado: (2017)

BMP9 Morphs into a Potential Player in Portopulmonary Hypertension
por: Toshner, Mark
Publicado: (2019)

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes
por: DuBrock, Hilary M., et al.
Publicado: (2019)

Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study
por: Shao, Yueming, et al.
Publicado: (2021)

Venous outflow obstruction and portopulmonary hypertension after orthotopic liver transplantation
por: Aguirre-Avalos, Guadalupe, et al.
Publicado: (2013)

Living donor liver transplantation in a patient with severe portopulmonary hypertension
por: Singh, Shweta A, et al.
Publicado: (2020)

Liver transplantation for severe portopulmonary hypertension: A case report and literature review
por: Chen, Xiao-Jie, et al.
Publicado: (2019)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report
por: Bremer, Hinrich C, et al.
Publicado: (2007)

Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg
por: DuBrock, Hilary M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3hqtecp0heai8k9jiv09rg9mmu